• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Draft Guidance on NDI Enforcement Discretion

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    Atlantia Clinical Trials

    Botanic Healthcare LLC

    Xsto Solutions

    Ecuadorian Rainforest
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Verdure Sciences

    Atlantia Clinical Trials

    Botanic Healthcare LLC

    Xsto Solutions

    Ecuadorian Rainforest
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Hemp Industry Experts Call for Unity in Turbulent Years to Come

    Murky regulatory status, competition from synthetic analogues, a global pandemic, and politics will present challenges to the hemp industry.

    Hemp Industry Experts Call for Unity in Turbulent Years to Come
    Related CONTENT
    • Jordan Process Receives Nutrasource ICAP Certification for CBD
    • Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    • Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    • FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    • HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    By Mike Montemarano, Associate Editor05.26.20
    At the Hemp Collective Summit, which took place virtually this year due to the COVID-19 pandemic, two industry leaders discussed the most beneficial ways in which the industries behind cannabidiol (CBD) and other hemp-derived products should brace themselves for a murky, high-stakes regulatory future.
     
    Since the enactment of the federal 2018 Farm Bill, legislation which allowed hemp farmers to grow and sell hemp-derived materials containing less than 0.3% THC, a patchwork of regulatory matters pertinent to hemp products have been enforced at different levels of discretion by all 50 U.S. states. Investor enthusiasm, consumer demand, and product launches exploded, peaking in 2019.
     
    John Grubb, managing partner at Summit Venture Management, described the hemp/CBD marketplace as adhering to “dog years,” in that the pace of the market dynamics in this arena move about seven times as quickly as those in any other segment of the dietary supplements industry.
     
    In spite of all this, there exists what Grubb described as a “broken link” in the regulatory structure surrounding CBD and hemp products at the federal level. While the 2018 Farm Bill, by all intents and purposes, was supportive by design of these products’ eventual path to market, no federal regulations exist to allow CBD or other hemp extracts to be sold directly as ingestibles (foods, beverages, or dietary supplements), greatly confounding the entire marketplace and consumers clamoring for extracts of the cannabis plant.
     
    “The FDA in its latest report wrote in a tone that left the market unsettled,” said United Natural Products Alliance (UNPA) President Loren Israelsen. He projected that a clear regulatory pathway for CBD supplements and other products to get to market may be as many as two to three years away. “The Farm Bill clearly shows intention to allow the lawful production of hemp to help farmers create a meaningful consumer products base for hemp. Where will these hemp products go if 75% of hemp production is tied into making CBD?”
     
    “The oxygen supply of this industry is diminishing,” Grubb said, after pointing to a number of severe valuation declines and spending cuts experienced by both small CBD businesses and also companies with the greatest amount of seed money and initial investment, largely brought on by the sheer regulatory risk involved in making advances in CBD products. Those getting in at the ground floor are facing a “tremendous amount of downward pressure,” Grubb added.
     
    Not every company that has put investments into CBD on the ground floor will weather the storm created by the uncertainty of the 2018 Farm Bill, but amid an estimated 1,500 to 3,500 brands that do, even the moderate projections for future CBD CAGRs are massive.

    Nonetheless, to see the industry dwindle down in competition would be a “tragedy,” Israelsen said. Further amplifying the difficulty in sustaining business is the COVID-19 pandemic. “COVID-induced sobriety is exacerbating retail challenges and smothering legislative priorities,” Grubb said. “There have been no meetings on The Hill despite many representatives showing sympathy to the industry for the broken link between the Farm Bill and the legalization of ingestible CBD.”
     
    Israelsen believes that, now more than ever, key players and investors in the CBD industry must present a unified front to federal regulators in pursuit of non-dietary ingredient acceptance for full-spectrum and broad spectrum hemp extracts, as well as CBD in dietary supplements, which will likely be the best shot for a clear, legal status on hemp extracts.
     
    NDI Likely to Trump GRAS
    “DSHEA (the Dietary Supplement Health and Education Act of 1994) provides a clear regulatory pathway to allow a substance that is approved as a drug to also be used as a dietary ingredient,” Israelsen said. CBD, as a molecule, has been patented as a drug called Epidiolex, which is used to treat seizures in children with rare, life-threatening disorders. “DSHEA never anticipated that one of these ingredients would be a controlled substance eventually released, which means that we would either need permission by FDA to submit these applications, or request that Congress directs the FDA to receive these NDI applications.”
     
    NDI status seems more achievable for CBD than the alternative GRAS (Generally Recognized As Safe) FDA status, due to the fact that NDIs require manufacturers to abide by maximum dosages made apparent to consumers. FDA will likely be much more resistant to offering CBD a GRAS status due to a number of trials indicating that the substance can cause liver damage in clinical settings, and due to the fact that so little is known about the long-term usage of CBD in high quantities. Dietary supplements are much more likely to be an approved format for CBD delivery than foods, which require all ingredients to have a GRAS status.
     
    “An NDI allows for a maximum, discrete dosage form,” Israelsen said. “It allows for cautionary language and explicit dosing language, and that can’t be done with food products. Foods have to be considered safe in any quantity, and FDA is concerned that a GRAS approach won’t take in the safety considerations involved with foods and beverages oversaturating the amount of allowable CBD and hemp extract constituents.”
     
    Widening the Spectrum
    Additionally, Israelsen said there is a broadening school of thought supporting the pursuit of approval for full- and broad-spectrum hemp extract as opposed to CBD, due to the fact that pharmaceutical companies are attempting to achieve patents on molecular isolates from hemp, and that there is a burgeoning development of synthetic CBD analogues which could achieve patent status through the benefits they provide. Already, isolates of the phytocannabinoids THCB and CBG are being studied for potential health benefits.
     
    “I think the wise choice is to recognize our situation, and leaders must recognize the collective benefits that naturally-derived hemp extract provides. We need order and harmony within this marketplace to police ourselves,” Israelsen said. “Some companies might naturally want to go alone, because the first company to get an NDI might be king of the mountain, and the advantage would be exceptional. I believe there will be multiple winners or no winners; no one individually will be able to convince FDA to give them what I believe will be the most difficult NDI to make.”
     
    Israelsen expressed doubts as to whether CBD could receive NDI designation at this point, now that it has been approved as a drug. For these reasons, he believes the best path forward is to pursue NDIs for full-spectrum hemp extracts, which contain over 120 cannabinoids excluding THC believed to be beneficial in many ways, along with flavonoids and terpenes which have known beneficial properties.
     
    “The FDA is reluctant to approve a dietary ingredient version of a recently-approved drug,” Israelsen said. “There is a broadening school of thought that hemp extract is the most appropriate subject of research, and can offer more product diversity.” Approaching NDI status for the whole plant provides a “richer pool of opportunity,” Israelsen said.
     
    With all of these stipulations in mind, synthetic hemp analogues are further challenging the long-term viability of an already-burdened fledgling market surrounding the herb that has been cultivated for thousands of years.
     
    “Companies are specializing in synthetic copies of cannabinoids,” Israelsen said. “They’ve organized themselves into a group that are also lobbying congress and FDA, and they’re seeking molecular neutrality between natural and synthetic, and are seeking out equal recognition with hemp benefits seen in the Farm Bill. They believe they can produce synthetics more cheaply than hemp-derived products, and have a competitive price advantage, and would like to move against pharmaceutical products to become generic producers.”

    Largely, it appears to most in the industry that synthetic alternatives would negate the incentives provided to hemp farmers, which were essentially the ends of the 2018 Farm Bill. Israelsen said members of Congress have been briefed on this issue, and that some seem intent to protect the naturally-derived hemp extract marketplace.
     
    “Congress will remember what they did in 2018 to help the farmer, and will recognize the existential threat that synthetic cannabinoids place on the industry,” Israelsen said.
     
    Whether any major moves in the political sphere will happen any time soon is another story, given how difficult it is for bills to pass at this time in large part due to the urgency in passing legislation related to COVID-19, and in part due to the politicking that will take place until November involving proponents of the 2018 Farm Bill, including Senate Majority Leader Mitch McConnell.
     
    “It’s exceptionally difficult to project any kind of timing due to COVID and Senator McConnell’s reelection campaign. There are greater electoral politics at play,” Israelsen said. “I believe that if Las Vegas was open right now they wouldn’t be taking bets on this. We have a short and treacherous pathway to protect the potential of this marketplace.”
    Related Searches
    • Research
    • Medical Nutrition
    • Dietary Supplements
    • Natural/Organic
    Related Knowledge Center
    • Regulations
    • Medical Nutrition
    • Quality & Safety
    Suggested For You
    Jordan Process Receives Nutrasource ICAP Certification for CBD Jordan Process Receives Nutrasource ICAP Certification for CBD
    Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation
    Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    Dietary Supplement Listing Bill Introduced in Senate Dietary Supplement Listing Bill Introduced in Senate
    Dietary Supplement ‘Champion,’ and DSHEA Architect, Sen. Orrin Hatch Dies at 88 Dietary Supplement ‘Champion,’ and DSHEA Architect, Sen. Orrin Hatch Dies at 88
    FDA Issues NAC Enforcement Discretion Guidance FDA Issues NAC Enforcement Discretion Guidance
    Steve Mister and Tara Falsani to Co-Chair ACI/CRN Dietary Supplements Forum Steve Mister and Tara Falsani to Co-Chair ACI/CRN Dietary Supplements Forum
    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research Beyond CBD: Cannabis Compounds Warrant Recognition and More Research
    FDA Seeks DSHEA Amendments FDA Seeks DSHEA Amendments
    Wegmans to Debut Dietary Supplements Verification Program Wegmans to Debut Dietary Supplements Verification Program

    Related Content

    • Breaking News | Certifications, Approvals & Patents | Herbs & Botanicals | Quality & Safety | Testing
      Jordan Process Receives Nutrasource ICAP Certification for CBD

      Jordan Process Receives Nutrasource ICAP Certification for CBD

      The company was the first raw material provider to join the certification program.
      05.18.22

    • Dietary Supplements | Regulations
      Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision

      Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision

      HELP Committee released discussion draft that includes language similar to Senate Bill 4090 introduced last month by Senators Durbin and Braun.
      By Sean Moloughney, Editor 05.18.22

    • Herbs & Botanicals | Quality & Safety | Testing
      Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients

      Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients

      The report concluded CBG, CBN, and CBC test articles were non-mutagenic, non-clastogenic, and non-genotoxic.
      05.06.22


    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations
      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      This marked the first time the agency took enforcement action against a delta-8 THC-containing product.
      05.04.22

    • HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe

      HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe

      Several botanicals and the clinical trials backing them will be featured.
      05.04.22

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Indena’s Meriva Curcumin Supplement May Benefit Kidney Function
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Test On Hydrolyzed Collagen Shows Resoundingly High Bioavailability | Nutraceuticals World
      Breaking News
      • GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      • Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      • Choline Alone May Improve Maternal DHA Status During Pregnancy
      • Cranberry Consumption Linked to Memory and Neurological Function Improvements
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Five PPG Facilities in Ohio Recognized for Sustainability, Health, Safety Practices
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      FDA Clears Arterys' AI Mapping and Quantification Tools
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      The World’s Most Popular Perfumes & Celebrity Fragrances
      Happi

      Latest Breaking News From Happi

      Silab Implements Biodiversity Conservation Project
      Indie Beauty Brand i-On Skincare Releases New Skin Emulsion, AI Diagnostic Tool
      Estée Lauder Companies' New Research on Oxidative Damage, Skin Barrier Function & Hyperpigmentation
      Ink World

      Latest Breaking News From Ink World

      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Award for Sustainability: Evonik Receives Platinum Rating Again
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nazdar celebrates 100th anniversary with refreshed brand identity
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      'Right' Hygiene Conference to be Held in June
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Cionic Expands Scientific Advisory Board
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell
      eMagin Wins People’s Choice Award at Display Week 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login